Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)
Titel:
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)
Auteur:
Claessens, Anouk K. M. Bos, Monique E. M. M. Lopez-Yurda, Marta Bouma, Jeanette M. Rademaker-Lakhai, Jeany M. Honkoop, Aafke H. Graaf, Hiltje de Druten, Edith van Warmerdam, Laurence J. C. van Sangen, Maurice J. C. van der Tjan-Heijnen, Vivianne C. G. Erdkamp, Frans L. G.